Cargando…
Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
Host-directed therapies are emerging as a promising tool in the curing of difficult-to-treat infections, such as those caused by drug-resistant bacteria. In this study, we aim to test the potential activity of the FDA- and EMA-approved drugs cysteamine and cystamine against Mycobacterium abscessus....
Autores principales: | Palucci, Ivana, Salustri, Alessandro, De Maio, Flavio, Pereyra Boza, Maria del Carmen, Paglione, Francesco, Sali, Michela, Occhigrossi, Luca, D’Eletto, Manuela, Rossin, Federica, Goletti, Delia, Sanguinetti, Maurizio, Piacentini, Mauro, Delogu, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866335/ https://www.ncbi.nlm.nih.gov/pubmed/36674717 http://dx.doi.org/10.3390/ijms24021203 |
Ejemplares similares
-
Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo
por: Jeitner, Thomas M., et al.
Publicado: (2018) -
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy
por: Alonzi, Tonino, et al.
Publicado: (2021) -
Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Diseases
por: Paul, Bindu D., et al.
Publicado: (2019) -
Transglutaminase type 2-dependent crosslinking of IRF3 in dying melanoma cells
por: Occhigrossi, Luca, et al.
Publicado: (2022) -
Type 2 transglutaminase in the nucleus: the new epigenetic face of a cytoplasmic enzyme
por: Rossin, Federica, et al.
Publicado: (2023)